SKK
CYTK icon

Shepherd Kaplan Krochuk’s Cytokinetics CYTK Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,436
Closed -$210K – 387
2015
Q3 		$210K Buy
+31,436
New +$215K 0.06% 258

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Shepherd Kaplan Krochuk's CYTK Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Cytokinetics (CYTK) in Q4 2015, closing a stake of 31,436 shares — an estimated $210K sold.

Shepherd Kaplan Krochuk first reported a position in CYTK in Q3 2015 and held it in 1 quarter. The position peaked at $210K in Q3 2015. 125 funds tracked by Wall St. Rank hold CYTK as of Q4 2015.

  • Shepherd Kaplan Krochuk reported no remaining Cytokinetics position as of Q4 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 31,436 Cytokinetics shares in Q4 2015, an estimated $210K.
  • Shepherd Kaplan Krochuk first reported a position in Cytokinetics in Q3 2015 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's Cytokinetics position peaked at $210K in Q3 2015.
  • 125 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.